Investment enables Ten Bio to establish new skin testing technology in USA
Pic shows Drs Conneely and Hickerson
“Tissue time machine” target for Dundee researcher with Wellcome Leap
A University of Dundee scientist has accepted a role to lead a $55 million initiative aiming to create a “tissue time machine” to fight disease.
New protein degradation centre to lead drug discovery revolution
A new translational research centre will bolster the University of Dundee’s world-leading position in a field of chemical biology that is revolutionising drug discovery, while helping to facilitate
Disease Area Strategist
Exscientia is at the forefront of Artificial Intelligence (AI) driven drug discovery and the first company to design drug molecules entirely by AI that are heading into the clinic. We are a technology company that combines the latest science and engineering with knowledge acquired from experienced medicinal chemists. This synergy allows us to automate drug discovery and so rapidly develop novel therapeutics on a large scale.
Experts to discuss what a post-Covid world might look like
A panel of experts will discuss what impact the Covid-19 pandemic and consequent lockdowns have had on society and consider what the future might look like i
Community testing for COVID-19 begins in Tayside
From Monday, 12 April, testing for people who do not have symptoms of COVID-19 will be available in communities across Tayside.
NHS Tayside awarded for Investing in Volunteers
NHS Tayside has received an Investing in Volunteers (IiV) award for supporting volunteers who provide a vital service for patients.
Diagnostics, Drugs, Data & Devices – How Will These Influence Patients & Outcomes In The Future?
-
Virtual
Tayside vaccination update
The COVID-19 vaccination programme is continuing at pace with almost 60% of the adult population in Tayside now had a jab.
This week’s numbers: